Dyne Therapeutics Director Kersten Offloads $5.46 Million in Stock
Dirk Kersten, a director at Dyne Therapeutics, Inc. (NASDAQ:DYN), executed a series of stock sales totaling approximately $5.46 million in late June 2026. The transactions were conducted under a Rule 10b5-1 trading plan adopted by ForDyne B.V. in November 2025. The sales occurred as the company's stock traded near $20.35, following a significant 91…